Substituted phenyl aziridine precursor analogs for inhibiting androgen-independent prostate cancer cell growth
申请人:Northwestern University
公开号:US10799475B2
公开(公告)日:2020-10-13
Disclosed are methods and pharmaceutical compositions for modulating one or more steroidal receptor activities. The methods typically utilize and the pharmaceutical compositions typically include one or more substituted phenyl aziridine precursors, their respective aziridines, analogs thereof, derivatives thereof, or pharmaceutically acceptable salts thereof such as CpdA. The methods and compositions may be used for treating diseases, disorders, and conditions associated with glucocorticoid receptor activity, androgen receptor activity, or both, such as cancers, acne vulgaris, and alopecia.
公开了调节一种或多种类固醇受体活性的方法和药物组合物。这些方法和药物组合物通常包括一种或多种取代苯基氮丙啶前体、各自的氮丙啶、其类似物、其衍生物或其药学上可接受的盐,如 CpdA。这些方法和组合物可用于治疗与糖皮质激素受体活性、雄激素受体活性或两者相关的疾病、失调和病症,如癌症、寻常痤疮和脱发。